journal article·2025-11

Dual‐Stage Drug Delivery Microspheres Amplify Tumor Starvation Through Coagulation‐Enhanced Vascular Occlusion

Kexin Wen, Yingjie Ren, Junjun Huang, Yuhan Mo, Jinqiao Zhang, Xianzhou Cai, Xinran Qu, Xiang Li, Yang Liu, Qin Fan, Ziliang Dong

Small· Volume 21· Issue 45
Publisher page

Abstract

Abstract Tumor starvation therapy aims to deprive tumors of essential nutrients but is often hindered by incomplete vascular occlusion and tumor metabolic adaptation. In this study, a pH‐responsive calcium carbonate (CaCO 3 ) embedded porous poly (lactic‐co‐glycolic acid) (PLGA) microsphere is developed to co‐deliver the small‐molecule vascular disrupting agent 5,6‐dimethylxanthenone‐4‐acetic acid (DMXAA) and thrombin, synergistically inducing cascaded intravascular coagulation and enhancing the efficacy of tumor‐starvation therapy. The incorporation of CaCO 3 nanoparticles not only increased the drug loading capacity but also endowed the microsphere with pH‐responsiveness, enabling the sequential release of DMXAA under acidic conditions to disrupt blood vessels and induce procoagulant factors exposure, followed by the release of thrombin, which, in combination with the Ca 2+ ions generated from the decomposition of CaCO 3 , further promoted blood clotting. In vascularized B16F10 murine melanoma models, these engineered microspheres demonstrate significant therapeutic potential through targeted induction of tumor‐associated intravascular thrombosis, resulting in marked anti‐tumor efficacy. Notably, in orthotopically implanted 4T1 mammary carcinoma models, the multifunctional particulates not only achieve primary tumor growth retardation but also effectively mitigate pulmonary metastatic dissemination. Thus, this work highlights a functional microsphere with sequential drug release capabilities, which can synergistically amplify tumor coagulation, leading to enhanced tumor‐starvation therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Science and Technology Innovation Center Shandong First Medical University & Shandong Academy of Medicine Sciences Jinan Shandong 250117 P. R. China

School of Chemistry Chemical Engineering and Biotechnology Nanyang Technological University 21 Nanyang Link Singapore 637371 Singapore

State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM) Nanjing University of Posts & Telecommunications Nanjing Jiangsu 210000 P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shandong Province · Natural Science Foundation of Jiangsu Province

References (37)

Show source-provided references
1. 10.1038/s41467-022-30436-y10.1038/s41467-022-30436-y ↗
2. 10.1038/nnano.2016.28010.1038/nnano.2016.280 ↗
3. 10.1038/s41467-019-13115-310.1038/s41467-019-13115-3 ↗
4. 10.1002/adma.20210450410.1002/adma.202104504 ↗
5. 10.1002/adma.20230941210.1002/adma.202309412 ↗
6. 10.1038/s41467-023-42691-810.1038/s41467-023-42691-8 ↗
7. 10.1038/s41551-020-0573-210.1038/s41551-020-0573-2 ↗
8. 10.1038/nbt.407110.1038/nbt.4071 ↗
9. 10.1016/j.addr.2022.11413810.1016/j.addr.2022.114138 ↗
10. 10.1002/adma.20231249310.1002/adma.202312493 ↗
11. 10.1038/s41419-024-06931-z10.1038/s41419-024-06931-z ↗
12. 10.1038/s41568-024-00736-010.1038/s41568-024-00736-0 ↗
13. 10.1038/s41467-023-44607-y10.1038/s41467-023-44607-y ↗
14. 10.1038/s41556-024-01440-910.1038/s41556-024-01440-9 ↗
15. 10.1038/s41392-024-01983-110.1038/s41392-024-01983-1 ↗
16. 10.3389/fcell.2024.151459510.3389/fcell.2024.1514595 ↗
17. 10.1126/sciadv.abn333310.1126/sciadv.abn3333 ↗
18. 10.1002/adma.20231321210.1002/adma.202313212 ↗
19. 10.1038/s41467-025-56407-710.1038/s41467-025-56407-7 ↗
20. 10.1038/s41467-023-36469-110.1038/s41467-023-36469-1 ↗
21. 10.1002/advs.20230774710.1002/advs.202307747 ↗
22. 10.1002/adma.20240875010.1002/adma.202408750 ↗
23. 10.1038/s41467-020-18177-210.1038/s41467-020-18177-2 ↗
24. 10.1126/sciadv.abb269510.1126/sciadv.abb2695 ↗
25. 10.1002/adma.20240329610.1002/adma.202403296 ↗
26. 10.1016/j.chempr.2024.10.00210.1016/j.chempr.2024.10.002 ↗
27. 10.1016/j.jconrel.2022.10.00210.1016/j.jconrel.2022.10.002 ↗
28. 10.1016/j.chempr.2020.02.02010.1016/j.chempr.2020.02.020 ↗
29. 10.1002/VIW.2020012610.1002/VIW.20200126 ↗
30. 10.1016/j.cclet.2022.05.03210.1016/j.cclet.2022.05.032 ↗
31. 10.1002/ange.20242194910.1002/ange.202421949 ↗
32. 10.1111/jth.1245510.1111/jth.12455 ↗
33. 10.1038/s41565-018-0319-410.1038/s41565-018-0319-4 ↗
34. 10.1016/j.nantod.2024.10221610.1016/j.nantod.2024.102216 ↗
35. 10.1007/s12274-020-2972-910.1007/s12274-020-2972-9 ↗
36. 10.1038/s41467-023-36045-710.1038/s41467-023-36045-7 ↗
37. 10.1002/adma.20180222810.1002/adma.201802228 ↗